AGIOS PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 101.63K shares, a 4377.09% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 14.28K shares, a 843.82% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 74.78K shares, a 37.47% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 89.61K shares, a 127.37% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 168.17K shares, a 51.02% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 343.34K shares, a 45.85% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 235.40K shares, a 1414.90% increase from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 15.54K shares, a 97.95% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 101.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 280.30K shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 14.28K shares 10-Q · filed 2026-04-29 | 180.94K shares derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | 74.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 168.17K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 89.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | 212.99K shares derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | 2.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 162.79K shares derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | 1.51K shares 10-Q · filed 2025-05-01 | 196.23K shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 119.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 343.34K shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 39.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 270.55K shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 35.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 266.88K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 148.63K shares 10-Q · filed 2024-05-02 | 252.54K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 46.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 235.40K shares 10-K · filed 2024-02-15 |
| 2023-09-30 | 35.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 198.65K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 21.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 164.31K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 131.49K shares 10-Q · filed 2023-05-04 | 143.78K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 10.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 15.54K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 1.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 19.50K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 824.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 85.61K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 3.25K shares 10-Q · filed 2022-05-05 | 639.51K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 14.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 758.68K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 67.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 766.20K shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 554.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 753.16K shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 122.42K shares 10-Q · filed 2021-04-29 | 349.99K shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 21.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 360.82K shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 54.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 369.16K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 151.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 387.00K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 133.26K shares 10-Q · filed 2020-04-30 | 309.60K shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | 29.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | 283.20K shares 10-K · filed 2020-02-19 |
| 2019-09-30 | 72.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 300.04K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 74.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 436.75K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 106.86K shares 10-Q · filed 2019-05-02 | 754.02K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 46.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | 1.13M shares 10-K · filed 2019-02-14 |
| 2018-09-30 | 209.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 1.28M shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 391.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.32M shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 477.85K shares 10-Q · filed 2018-05-04 | 1.07M shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | 200.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | 730.48K shares 10-K · filed 2018-02-14 |
| 2017-09-30 | 252.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 736.07K shares derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | 134.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 566.93K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 142.54K shares 10-Q · filed 2017-05-04 | 555.49K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 206.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 603.36K shares 10-K · filed 2017-02-16 |
| 2016-09-30 | 83.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 488.04K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 122.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 588.78K shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 190.41K shares 10-Q · filed 2016-05-09 | 575.70K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 91.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 560.32K shares 10-K · filed 2016-02-26 |
| 2015-09-30 | 184.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 639.90K shares derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-06-30 | 109.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 670.71K shares derived: sum of 4 quarters · filed 2015-08-07 |
| 2015-03-31 | 175.03K shares 10-Q · filed 2015-05-11 | 848.79K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 170.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 1.30M shares 10-K · filed 2015-02-24 |
| 2014-09-30 | 215.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2014-06-30 | 287.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | |
| 2014-03-31 | 625.02K shares 10-Q · filed 2014-05-09 | |
| 2013-12-31 | 237.56K shares 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |